Sodium fusidate (Fucidin®,) tablets are indicated for the treatment of infections caused by susceptible organisms, especially staphylococci, e.g. osteomyelitis, septicaemia, endocarditis, superinfected cystic fibrosis, pneumonia, skin and soft tissue infections, surgical and traumatic wound infections.
Place of Origin
France
Product Usage
Adults and children over 12 years: 500 mg (2 tablets) three times a daily. Recommended dosage in skin and soft tissue infections: 250 mg sodium fusidate (1 tablet) twice daily. Dosage may be doubled in severe cases. According to the metabolism and excretion of systemic sodium fusidate (Fucidin®), no dosage adjustment is needed in renal impairment or in patients undergoing haemodialysis as fusidic acid is not significantly dialysed.
Ingredients
Each film-coated tablet contains sodium fusidate 250 mg The tablet is an approximately 7.8 x 16.0 mm white to off-white greyish marbled film-coated oval biconvex tablet without embossing.
Warnings
Contraindications: Hypersensitivity to the active substance or to any of the excipients. Concomitant treatment with statins (HMG-CoA reductase inhibitors). (See Special Warnings and Precautions for Use and Interaction with Other Medicinal Products and Other Forms of Interaction) Special Warnings and Precautions for Use Statins (HMG-CoA reductase inhibitors) and systemic Sodium fusidate (Fucidin®) must not be co-administered
Width
1
Height
1
Depth
1